Ryuzo Yamaguchi

Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)

Katsuhiko Uesaka, Narikazu Boku, Akira Fukutomi et al. · The Lancet · 2016 · 1.1K citations

Surgical Oncology, Oncology, Pancreatic Cancer +6

Colorectal obstruction is a potential prognostic factor for stage II colorectal cancer

Yusuke Okuda, Takaya Shimura, Tomonori Yamada et al. · International Journal of Clinical Oncology · 2018 · 69 citations

Colorectal Obstruction, Colorectal Surgery, Medicine +7

Health-related quality of life of adjuvant chemotherapy with S-1 versus gemcitabine for resected pancreatic cancer: Results from a randomised phase III trial (JASPAC 01)

Yasuhiro Hagiwara, Yasuo Ohashi, Katsuhiko Uesaka et al. · European Journal of Cancer · 2018 · 20 citations

Surgical Oncology, Pancreatic Cancer, Health-related Quality +8

Phase 2 Trial of Adjuvant Chemotherapy With S − 1 for Node-Positive Biliary Tract Cancer (N-SOG 09)

Kazuaki Seita, Tomoki Ebata, Takashi Mizuno et al. · Annals of Surgical Oncology · 2020 · 19 citations

Surgical Oncology, Medicine, Biliary Cancer +8

Pathobiological Implications of Mucin (MUC) Expression in the Outcome of Small Bowel Cancer

Hiroaki Shibahara, Michiyo Higashi, Chihaya Koriyama et al. · PLoS ONE · 2014 · 16 citations · Full text